Skip to content

PHYSICIAN PRESCRIBED PEPTIDES  ·  COMPOUNDED BY A 503A PHARMACY  ·  PROVIDER REVIEW TYPICALLY UNDER 24 HOURS

Get Started →

Now leaving

AnthologyRX+

You are being taken to our partner site for prescription longevity care. It is a separate storefront: prescribing, pharmacy fulfillment, pricing and terms are handled separately.

AnthologyRX

Does PT-141 really work? Yes, for the right problem, and that is the entire catch.

Start with the strongest fact: bremelanotide, the molecule PT-141 refers to, is FDA-approved for low sexual desire in premenopausal women under the brand Vyleesi. Desire drugs that clear that bar are rare, and this one did. What we prescribe is compounded PT-141 after clinician review, for men and for women, and the honest answer to the headline question has two halves: the mechanism is real, and it only helps if your problem is the one it addresses.

The short answer

PT-141 works on desire through the nervous system, not on blood flow. If your problem is that the body does not cooperate while the interest is fine, this is the wrong tool and the ED pills are the right conversation. If the interest itself has gone quiet, PT-141 is one of the only medicines aimed at exactly that, and response varies person to person in a way your clinician will be straight with you about. It also has real side effects, nausea most commonly, which is part of why it is a prescription with a screening step and not a supplement.

Why do reviews on it disagree so much?

Because half the people reviewing it took it for the wrong problem. A desire-pathway drug judged as a performance drug will always read as a coin flip. Judged against the problem it actually addresses, the picture is more consistent, which is why the Assessment asks what is actually going on rather than which product you want.

Questions

What happens if I am not approved?

You are not charged. Your clinician explains the reasoning and, where useful, what a better next step may be. Reviews are typically completed in under 24 hours.

Is this FDA approved?

Bremelanotide is FDA-approved as Vyleesi for a specific indication in premenopausal women. What we prescribe is compounded PT-141, and no compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.

Does it work for men?

The desire pathway it acts on is not exclusive to women, and clinicians do prescribe it for men. Whether it fits your case is what the review decides.

Ready when you are.

About 10 minutes. No charge unless your clinician approves.